Medical News

RSS

Personalized navigation support increases genetic testing among cancer patients' relatives

Among cancer patients who received personalized support and navigation services from experts throughout the genetic testing process, their first-degree relatives – parents, siblings and children – were significantly more likely to receive genetic testing, as well.

30 Sep 2026

New AI framework personalizes supportive care for cancer survivors

Researchers with Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have created a framework for developing, evaluating and implementing AI tools in cancer survivorship and supportive care, according to a new proof-of-concept study published in the journal Translational Behavioral Medicine.

30 Sep 2026

New mathematical model tracks how tumor environment impacts cancer therapies

Researchers from Mass General Brigham and the University of Cyprus have developed a sophisticated mathematical model to better understand how the tumor microenvironment affects the delivery and effectiveness of a new type of cancer therapy called an immunomodulatory antibody-drug conjugate (IM-ADC).

30 Sep 2026

Young adults using AI for health questions may screen positive for anxiety and depression

Young adults who use generative artificial intelligence to ask health-related questions are more likely to screen positive for clinically significant anxiety and depression than those not using the AI tool for health issues, according to a new study led by University of Florida researcher Yusen Zhai.

30 Sep 2026

Fractionated radiation reduces brain cancer recurrence and boosts survival

Mayo Clinic researchers led a multicenter study that found dividing radiation into several treatments, known as fractionated stereotactic radiosurgery, reduced the risk of cancer returning after surgery for brain metastases and was associated with improved survival compared with delivering radiation in a single treatment.

30 Sep 2026

Laverock Therapeutics announces in vivo programs in oncology and genetic medicine

Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announces its in vivo programs spanning CAR-T and genetic medicine

From Laverock Therapeutics 30 Sep 2026

Daily probiotics help prevent severe gut disease in preterm babies

Probiotic supplementation in very preterm infants is linked to lower rates of necrotizing enterocolitis and mortality, according to a nationwide Swedish study.

30 Sep 2026

Owning a smartphone at 12 linked to eating disorder symptoms

Early smartphone use is linked to a rise in eating disorder symptoms among adolescents, indicating potential mental health implications that require attention.

30 Sep 2026

Streamlining CRISPR workflows, from editing to analysis

INTEGRA's automated solutions optimize CRISPR workflows, enhancing gene editing efficiency and accelerating the path to innovative therapeutic developments.

From INTEGRA Biosciences 30 Sep 2026

Mouser stocking nearly 70,000 products from leading global passive component manufacturer YAGEO Group

Mouser Electronics, Inc., an authorized global distributor with the widest selection of semiconductors and electronic components, is shipping a wide array of new products and solutions from the YAGEO Group, a leading global passive component manufacturer.

From Mouser 30 Sep 2026

AtlasPlex™ brings custom 5-plex IHC on FFPE tissue into a single day

Atlas Antibodies has launched AtlasPlex™, a new ready-to-use multiplex immunohistochemistry kit. It lets researchers build their own 3- or 5-plex panels from more than 17,000 IHC-validated antibodies covering over 12,000 human genes.

From Atlas Antibodies AB 30 Sep 2026

Atlas Antibodies marks 20 years of Human Protein Atlas–validated antibodies

Atlas Antibodies is 20 years old. The company is the original manufacturer of the antibodies used to map the human proteome in the Human Protein Atlas (HPA).

From Atlas Antibodies AB 30 Sep 2026

MolBoolean™ measures free and bound proteins in the same experiment

Atlas Antibodies has launched MolBoolean™, a new in situ proximity assay. It detects free protein A, free protein B, and the A–B complex together in fixed cells and tissue.

From Atlas Antibodies AB 30 Sep 2026

Exercise linked to better attention and memory after breast cancer

One in three breast cancer survivors will experience cognitive problems, which can include difficulties with attention, memory, processing speed and other aspects of thinking.

29 Sep 2026

Weekly cisplatin fails to reduce acute toxicity in advanced head and neck cancer

Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer.

29 Sep 2026

Petrelintide produces double-digit weight loss with fewer side effects

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that weekly injections with the new amylin-based obesity drug petrelintide can enable those treated to lose more than 10% of their body weight – generally lower than existing incretin-based (GLP-1 RA) drugs, but also with far fewer side effects.

29 Sep 2026

Flexible work and fair pay could help create healthier jobs, researchers say

Fewer late-night emails and greater flexibility at work could help keep millions of people healthier, according to experts at the University of East Anglia.

29 Sep 2026

Researchers found a curious mitochondrial pattern in people who moved more

Researchers found that greater self-reported activity, walking, and accelerometer-measured light activity were associated with higher mitochondrial DNA copy number in 256 healthy middle-aged adults. The cross-sectional findings cannot establish causation, and the very low amount of vigorous activity means they do not show that light movement is more beneficial than higher-intensity exercise.

29 Sep 2026

People with evening chronotypes face higher risk of early disability retirement

People with evening chronotypes have a 1.7 fold elevated risk of needing to retire early and take a disability pension compared with morning chronotypes, suggest the findings of research published online in the journal Occupational & Environmental Medicine.

29 Sep 2026

Cold temperatures may raise eye pressure in glaucoma patients

Lower air temperatures may be associated with an increase in the fluid pressure inside the eye-a cardinal cause of glaucoma-and should be taken into consideration when treating patients with the condition, suggest the findings of research published online in the British Journal of Ophthalmology.

29 Sep 2026